| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |